Drug
DG3173
DG3173 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
40%(2 trials)
Phase Distribution
Ph phase_2
2
40%
Ph phase_1
3
60%
Phase Distribution
3
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
3(60.0%)
Phase 2Efficacy & side effects
2(40.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 13 (60.0%)
Phase 22 (40.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_2
Single Dose Pharmacology Study of DG3173 and Octreotide in Acromegalic Patients.
NCT02235987
completedphase_2
The Effect of Subcutaneous Infusions of 3 Doses of DG3173 on Growth Hormone Levels in Untreated Acromegalics
NCT02217800
completedphase_1
Single Dose Pharmacodynamic and Pharmacokinetic Study of DG3173
NCT02217826
completedphase_1
Single Ascending Dose Tolerability Study of DG3173
NCT02217488
completedphase_1
Multiple Ascending Dose Tolerability, Pharmacokinetic and Pharmacodynamic Study of DG3173
NCT02217839
Clinical Trials (5)
Showing 5 of 5 trials
NCT02235987Phase 2
Single Dose Pharmacology Study of DG3173 and Octreotide in Acromegalic Patients.
NCT02217800Phase 2
The Effect of Subcutaneous Infusions of 3 Doses of DG3173 on Growth Hormone Levels in Untreated Acromegalics
NCT02217826Phase 1
Single Dose Pharmacodynamic and Pharmacokinetic Study of DG3173
NCT02217488Phase 1
Single Ascending Dose Tolerability Study of DG3173
NCT02217839Phase 1
Multiple Ascending Dose Tolerability, Pharmacokinetic and Pharmacodynamic Study of DG3173
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5